Annals of the Rheumatic Diseases
IF
16.10
Papers
50017
Papers 10000
1 page of 1,000 pages (10k results)
Newest
#1Ulf Lindström (University of Gothenburg)H-Index: 13
#2Daniela Di Giuseppe (KI: Karolinska Institutet)H-Index: 14
Last. Michael John Nissen (Geneva College)H-Index: 15
view all 31 authors...
BACKGROUND Comedication with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) during treatment with tumour necrosis factor inhibitors (TNFi) is extensively used in psoriatic arthritis (PsA), although the additive benefit remains unclear. We aimed to compare treatment outcomes in patients with PsA treated with TNFi and csDMARD comedication versus TNFi monotherapy. METHODS Patients with PsA from 13 European countries who initiated a first TNFi in 2006-2017 were included. Cou...
Source
Source
#1Scott A. Jenks (Emory University)H-Index: 15
#2Chungwen Wei (Emory University)H-Index: 23
Last. Ignacio Sanz (Emory University)H-Index: 34
view all 13 authors...
OBJECTIVE While the contribution of B-cells to SLE is well established, its role in chronic cutaneous lupus erythematosus (CCLE) remains unclear. Here, we compare B-cell and serum auto-antibody profiles between patients with systemic lupus erythematosus (SLE), CCLE, and overlap conditions. METHODS B-cells were compared by flow cytometry amongst healthy controls, CCLE without systemic lupus (CCLE+/SLE-) and SLE patients with (SLE+/CCLE+) or without CCLE (SLE+/CCLE-). Serum was analyed for autorea...
Source
Source
Source
Source
Source
Source
Source
Source
12345678910
Top fields of study
Internal medicine
Physical therapy
Immunology
Arthritis
Rheumatoid arthritis
Diabetes mellitus
Medicine